These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 34265147)

  • 1. Renewed interests in the discovery of bioactive actinomycete metabolites driven by emerging technologies.
    Ossai J; Khatabi B; Nybo SE; Kharel MK
    J Appl Microbiol; 2022 Jan; 132(1):59-77. PubMed ID: 34265147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture.
    Kim JH; Lee N; Hwang S; Kim W; Lee Y; Cho S; Palsson BO; Cho BK
    J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 33825906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery.
    Subramani R; Aalbersberg W
    Appl Microbiol Biotechnol; 2013 Nov; 97(21):9291-321. PubMed ID: 24057404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic biology and metabolic engineering of actinomycetes for natural product discovery.
    Palazzotto E; Tong Y; Lee SY; Weber T
    Biotechnol Adv; 2019 Nov; 37(6):107366. PubMed ID: 30853630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications and Restrictions of Integrated Genomic and Metabolomic Screening: An Accelerator for Drug Discovery from Actinomycetes?
    Krause J
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain improvement in actinomycetes in the postgenomic era.
    Baltz RH
    J Ind Microbiol Biotechnol; 2011 Jun; 38(6):657-66. PubMed ID: 21253811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes.
    Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):343-70. PubMed ID: 26364200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics-Driven Natural Product Discovery in Actinomycetes.
    Niu G
    Trends Biotechnol; 2018 Mar; 36(3):238-241. PubMed ID: 29126570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural product discovery: past, present, and future.
    Katz L; Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):155-76. PubMed ID: 26739136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuing hunt for endophytic actinomycetes as a source of novel biologically active metabolites.
    Masand M; Jose PA; Menghani E; Jebakumar SR
    World J Microbiol Biotechnol; 2015 Dec; 31(12):1863-75. PubMed ID: 26410426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Genomic Survey of the Natural Product Biosynthetic Potential of Actinomycetes Isolated from New Zealand Lichens.
    Hou P; Nowak VV; Taylor CJ; Calcott MJ; Knight A; Owen JG
    mSystems; 2023 Apr; 8(2):e0103022. PubMed ID: 36749048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lorneic Acid Analogues from an Endophytic Actinomycete.
    Yang R; Yang J; Wang L; Huang JP; Xiong Z; Luo J; Yu M; Yan Y; Huang SX
    J Nat Prod; 2017 Oct; 80(10):2615-2619. PubMed ID: 28990780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endophytic actinomycetes: promising source of novel bioactive compounds.
    Matsumoto A; Takahashi Y
    J Antibiot (Tokyo); 2017 May; 70(5):514-519. PubMed ID: 28270688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marine actinomycetes as an emerging resource for the drug development pipelines.
    Zotchev SB
    J Biotechnol; 2012 Apr; 158(4):168-75. PubMed ID: 21683100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary Metabolites of Endophytic Actinomycetes: Isolation, Synthesis, Biosynthesis, and Biological Activities.
    Bernardi DI; das Chagas FO; Monteiro AF; Dos Santos GF; de Souza Berlinck RG
    Prog Chem Org Nat Prod; 2019; 108():207-296. PubMed ID: 30924015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous expression-facilitated natural products' discovery in actinomycetes.
    Xu M; Wright GD
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):415-431. PubMed ID: 30446891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gifted microbes for genome mining and natural product discovery.
    Baltz RH
    J Ind Microbiol Biotechnol; 2017 May; 44(4-5):573-588. PubMed ID: 27520548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
    Rebets Y; Brötz E; Tokovenko B; Luzhetskyy A
    J Ind Microbiol Biotechnol; 2014 Feb; 41(2):387-402. PubMed ID: 24127068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecological Strategies Behind the Selection of Cultivable Actinomycete Strains from the Yucatan Peninsula for the Discovery of Secondary Metabolites with Antibiotic Activity.
    Parera-Valadez Y; Yam-Puc A; López-Aguiar LK; Borges-Argáez R; Figueroa-Saldivar MA; Cáceres-Farfán M; Márquez-Velázquez NA; Prieto-Davó A
    Microb Ecol; 2019 May; 77(4):839-851. PubMed ID: 30761424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on Molecular Tools for Genetic Engineering of Actinomycetes-The Source of Important Antibiotics and Other Valuable Compounds.
    Mitousis L; Thoma Y; Musiol-Kroll EM
    Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32784409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.